B. GEMİCİOĞLU And B. Civici, "Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years," American Thoracic Society International Conference , Philadelphia, United States Of America, pp.18, 2013
GEMİCİOĞLU, B. And Civici, B. 2013. Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years. American Thoracic Society International Conference , (Philadelphia, United States Of America), 18.
GEMİCİOĞLU, B., & Civici, B., (2013). Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years . American Thoracic Society International Conference (pp.18). Philadelphia, United States Of America
GEMİCİOĞLU, Bilun, And Berna Civici. "Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years," American Thoracic Society International Conference, Philadelphia, United States Of America, 2013
GEMİCİOĞLU, Bilun And Civici, Berna. "Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years." American Thoracic Society International Conference , Philadelphia, United States Of America, pp.18, 2013
GEMİCİOĞLU, B. And Civici, B. (2013) . "Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years." American Thoracic Society International Conference , Philadelphia, United States Of America, p.18.
@conferencepaper{conferencepaper, author={Bilun GEMİCİOĞLU And author={Berna Civici}, title={Omalizumab Responsive Patients Maintained Their Asthma Control And Had Less Severe Exacerbations After Five Years}, congress name={American Thoracic Society International Conference}, city={Philadelphia}, country={United States Of America}, year={2013}, pages={18} }